# 21.02 Platform release now live!

**URL:** <https://community.opentargets.org/t/21-02-platform-release-now-live/16>\
**Category:** Releases\
**Created:** [8 March 2021 14:35 UTC](https://community.opentargets.org/t/21-02-platform-release-now-live/16 "2021-03-08T14:35:31Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![community\_manager](https://dub1.discourse-cdn.com/flex017/user_avatar/community.opentargets.org/community_manager/32/10_2.png) [@community\_manager](https://community.opentargets.org/u/community_manager)\
**Post date:** [8 March 2021 14:35 UTC](https://community.opentargets.org/t/21-02-platform-release-now-live/16/1 "2021-03-08T14:35:31Z")

</div>

In our first release of 2021, we integrate **10,078,746 evidence strings** to build **7,385,188 target-disease associations** between **14,416 diseases** and **27,650 targets** from the following **19 public resources and databases**.

Evidence strings breakdown by data source:

- 794,360 genetic evidence from [European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 388,346 genetic evidence from [Open Targets Genetics Portal](https://genetics.opentargets.org/)
- 2,418 genetic evidence from [Gene2Phenotype](https://www.ebi.ac.uk/gene2phenotype)
- 20,911 genetic evidence from the [Genomics England PanelApp](https://bioinfo.extge.co.uk/crowdsourcing/PanelApp/)
- 1,187 genetic evidence from [ClinGen](https://search.clinicalgenome.org/kb/gene-validity/)
- 183,643 genetic evidence from the [PheWAS catalog](https://phewascatalog.org/)
- 5,269 genetic evidence from [UniProt Literature](https://www.uniprot.org/)
- 10,457 somatic evidence from [European Variation Archive (EVA)](http://www.ebi.ac.uk/eva/)
- 3,342 somatic evidence from [intOGen](https://www.intogen.org/)
- 61,666 somatic evidence from the [Cancer Gene Census](http://cancer.sanger.ac.uk/census/)
- 442,053 drug evidence from [ChEMBL](https://www.ebi.ac.uk/chembl/)
- 217,307 expression evidence from [Expression Atlas](https://www.ebi.ac.uk/gxa/home)
- 18,393 affected pathway evidence from [Reactome](https://reactome.org/)
- 74,546 affected pathway evidence from [SLAPenrich](https://saezlab.github.io/SLAPenrich/)
- 308 affected pathway evidence from [PROGENy](https://saezlab.github.io/progeny/)
- 408 systems biology evidence from [SysBio](https://saezlab.github.io/progeny/)
- 1,846 CRISPR-Cas9 (Cancer Cell Lines) evidence from [Behan et al. 2019](https://europepmc.org/abstract/MED/30971826)
- 710,319 mouse model evidence from [PhenoDigm](https://www.sanger.ac.uk/resources/databases/phenodigm)
- 6,699,914 scientific literature evidence from co-occurence mining in [Europe PMC](https://europepmc.org/)

Key highlights for this release include:

- Data updates from ChEMBL, ClinGen, Europe PMC. EVA, Gene2Phenotype, PhenoDigm, Reactome, UniProt
- Updates to our [COVID-19 Target Prioritisation Tool](http://covid19.opentargets.org/)
- Preview link to [Beta release of new version of Platform](https://beta.targetvalidation.org/)

For more details, check our [21.02 release blog post](http://blog.opentargets.org/2021/02/17/open-targets-platform-21-02-release/) and [21.02 technical notes](https://docs.targetvalidation.org/technical-pipeline/technical-notes#21-02).